Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 100
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: UHN REB 08-0106-C
Study First Received: November 21, 2008
Last Updated: August 30, 2016
Estimated Primary Completion Date: July 2017
Primary Outcome Measures:
The primary outcome for the study will be the proportion of patients treated as per protocol without treatment related mortality.|To evaluate: acute and late morbidity related to treatment; local & distant recurrence, disease free & overall survival; identify factors/parameters associated with increased risk of treatment morbidity
Sponsors and Collaborators:
University Health Network, Toronto
Website Link: https://ClinicalTrials.gov/show/NCT00797719
